H-Index
12
Scimago Lab
powered by Scopus
eISSN: 1941-5923

Logo



Get your full text copy in PDF

A fatal case of secondary gain; a cautionary tale

Michael D. Freeman, Christopher Centeno

Am J Case Rep 2008; 9:97-103

ID: 828544


Background: The term “secondary gain” is rarely heard outside of a medicolegal context, and is a disparaging term used to describe a patient with a compensable injury in whom symptom exaggeration or fabrication is suspected. The allegation of secondary gain is difficult to confirm, and may arise from a lack of an appropriate diagnostic evaluation and proper attribution of symptoms to pathology. Additionally, clinicians who allege secondary gain or malingering in a patient in the absence of clear evidence may be motivated by economic incentives to make such determinations.
Case Report: We present a tragic case study in which a 32-year-old man with obvious signs of acute posttraumatic cervical myelopathy was subjected to multiple evaluations by more than 10 various clinicians over an 8 month period before he was referred for a cervical spine MRI. Although the patient underwent surgery to decompress the lesion, ultimately he died from an overdose of narcotic pain medication associated with a residual central cord pain syndrome.
Conclusions: There were a variety of systematic or “secondary gain” pressures acting on the clinicians in this case that may have led to the lack of a definitive diagnosis and the resulting improper care. This included a business model that emphasized repeated treatment in the case of the treating chiropractors and the desire for future employment in the case of the physician performing the insurer-mandated evaluation. It is reasonable to examine the motivation of clinicians who allege secondary gain in a patient in a third party evaluation setting.

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree